Protocols cure diseases, not patients: flaccid paresis in post-NSTEMI statin treatment. [electronic resource]
Producer: 20160115ISSN:- 1757-790X
- Adrenergic beta-Antagonists -- therapeutic use
- Aged, 80 and over
- Atorvastatin -- adverse effects
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- adverse effects
- Myocardial Infarction -- therapy
- Paresis -- chemically induced
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors -- therapeutic use
- Rhabdomyolysis -- chemically induced
- Stents
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.